During the past decade, Hanyang University Guri Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 20 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 16 clinical trials were completed. i.e. 106.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hanyang University Guri Hospital" #1 sponsor was "Celgene" with 8 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Hanyang University" with 6 trials sponsored, "Pfizer" with 6 trials sponsored and "Chong Kun Dang Pharmaceutical" with 6 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hanyang University Guri Hospital" #1 collaborator was "Hanyang University" with 5 trials as a collaborator, "Chung-Ang University Hosptial, Chung-Ang University College of Medicine" with 3 trials as a collaborator, "Inje University" with 3 trials as a collaborator, "Kangbuk Samsung Hospital" with 3 trials as a collaborator and "Pusan National University Hospital" with 3 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Hanyang University Guri Hospital" are "Crohn Disease" (7 trials), "Ulcerative Colitis" (7 trials), "Crohn's Disease" (5 trials), "Type 2 Diabetes" (4 trials) and "Chronic Hepatitis B" (3 trials). Many other conditions were trialed in "Hanyang University Guri Hospital" in a lesser frequency.

Most popular intervention types in "Hanyang University Guri Hospital" are "Drug" (59 trials), "Other" (7 trials), "Device" (6 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "GED-0301" (3 trials), "Insulin Degludec" (3 trials), "Ozanimod" (3 trials) and "Bismuth-Containing Quadruple Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hanyang University Guri Hospital" are 68 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hanyang University Guri Hospital". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Hanyang University Guri Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hanyang University Guri Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 2 trials that are defined as “Not Applicable".